Banner

Quiz: Patient experiences sudden decrease in vision

Publication
Article
Optometry Times JournalFebruary digital edition 2021
Volume 13
Issue 2

quick quiz

Quiz accompanies THIS article from our February issue

What is the most common visual field defect seen in ischemic optic neuropathy?

A. Central scotoma

B. Altitudinal

C. Arcuate

D. Cecocentral


Articles in this issue
Quiz: Patient experiences sudden decrease in vision
Quiz: Patient experiences sudden decrease in vision
Soft toric lens fitting practices not meeting patient needs
Soft toric lens fitting practices not meeting patient needs
Review Duane’s retraction syndrome diagnosis and treatment
Review Duane’s retraction syndrome diagnosis and treatment
Point-of-care testing helps dry eye diagnosis
Point-of-care testing helps dry eye diagnosis
Patient experiences sudden decrease in vision
Patient experiences sudden decrease in vision
How to improve telehealth
How to improve telehealth
High IOP, uveitis lead to Posner-Schlossman diagnosis
High IOP, uveitis lead to Posner-Schlossman diagnosis
Differential key to diagnosing idiopathic orbital inflammation
Differential key to diagnosing idiopathic orbital inflammation
How to avoid patient nonadherence
How to avoid patient nonadherence
Related Videos
Janis Winters, OD, FAAO
Justin Schweitzer and Nate Lighthizer discuss surgical interventions in glaucoma at AOA 2023.
Justin Schweitzer and Nate Lighthizer discuss surgical interventions in glaucoma at AOA 2023.
Dr. Mohammad Rafieetary
Related Content

Iveric Bio releases 24-month topline results from Phase 3 study of avacincaptad pegol intravitreal solution (IZERVAY) for geographic atrophy

September 19th 2023

Open your eyes: diabetes of the eye (part 2)

January 10th 2022

This is what eye care providers need to know about type 1 diabetes

August 28th 2023

Open your eyes: diabetes of the eye

January 3rd 2022

Geographic atrophy is a major concern in eye health

August 21st 2023

Regeneron receives FDA approval for aflibercept injection 8mg for treatment of wet AMD, DME, DR

August 19th 2023

Iveric Bio releases 24-month topline results from Phase 3 study of avacincaptad pegol intravitreal solution (IZERVAY) for geographic atrophy

September 19th 2023

Open your eyes: diabetes of the eye (part 2)

January 10th 2022

This is what eye care providers need to know about type 1 diabetes

August 28th 2023

Open your eyes: diabetes of the eye

January 3rd 2022

Geographic atrophy is a major concern in eye health

August 21st 2023

Regeneron receives FDA approval for aflibercept injection 8mg for treatment of wet AMD, DME, DR

August 19th 2023

Iveric Bio releases 24-month topline results from Phase 3 study of avacincaptad pegol intravitreal solution (IZERVAY) for geographic atrophy

September 19th 2023

Open your eyes: diabetes of the eye (part 2)

January 10th 2022

This is what eye care providers need to know about type 1 diabetes

August 28th 2023

Open your eyes: diabetes of the eye

January 3rd 2022

Geographic atrophy is a major concern in eye health

August 21st 2023

Regeneron receives FDA approval for aflibercept injection 8mg for treatment of wet AMD, DME, DR

August 19th 2023
© 2023 MJH Life Sciences

All rights reserved.